1. Home
  2. >Invitris
Invitris logo

Invitris

Creating new protein-based drugs at scale

Company

Locations
Munich, BY, Germany
Team Size
6
Industries
Healthcare, Drug Discovery and Delivery
About
Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.

Founders

A list of all active founders
NameTitleEmail
Patrick Grossmann
Founder
Kilian Vogele
Founder